Tweenvest Stocks

Grapefruit USA, Inc. (OTCPK: GPFT)

Health Care · Pharmaceuticals · US

$0.00

-35.48% today · -93.3% 1Y

Grapefruit USA, Inc. (OTCPK: GPFT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $116.19K and employs 9 people.

Over the last twelve months the share price has lost 93.3%, trading between 0.00 and 0.00.

Tweenvest scores Grapefruit USA, Inc. across four factors: quality 8/100, value 55/100. Its strongest factor is value.

GPFT price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$116.19K
Revenue (TTM)
$34.85K
P/E
EPS
-0.01
Dividend yield
Beta (5Y)
0.10
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
Shares outstanding
1.16B
Employees
9
Next earnings

About Grapefruit USA, Inc.

Grapefruit USA, Inc. is a company dedicated to the creation and distribution of cannabis-related goods, primarily serving the California market. A key offering from the firm is Hourglass, a topical cream featuring a sustained-release blend of THC and CBD, which is exclusively sold via its online platform. The business, originally established in 2017, was formerly recognized as Grapefruit Boulevard Investments, Inc., before officially adopting its current name, Grapefruit USA, Inc., in January 2020. Its main operational base is situated in Wilmington, Delaware.

Founded
2017
Listed since
Jun 23, 2016
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.12T$1,255.40+0.88%
Johnson & JohnsonNYSE: JNJ$651.25B$270.24+1.07%
Merck & Co., Inc.NYSE: MRK$376.37B$152.55+2.39%
Roche Holding AGSWX: ROP$373.91BCHF375.60+1.02%
Novartis AGSWX: NOVN$302.17BCHF127.42+0.85%
AstraZeneca PLCLSE: AZN$258.76B£122.40+1.26%
Novo Nordisk A/SCPSE: NOVO B$207.84BDkr300.85+1.59%
Pfizer Inc.NYSE: PFE$159.99B$28.07+1.01%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.